Imugene moves forward with cancer vax trial news release

MELBOURNE: Paul Hopper’s $2.7 billion cancer biotech Imugene will move forward with trials ... read more

Woolworths battle to take Priceline could change pharmacy market

MELBOURNE: Across the world, from the UK to the US and New Zealand ... read more

Woolworths facing a harder road in API tilt

MELBOURNE: Analysts say supermarket giant Woolworths has a harder road to travel than ... read more

CSL to appeal after losing challenge to donor ban

MELBOURNE: Biotech giant CSL plans to appeal its loss in a court challenge ... read more